» Articles » PMID: 35964133

Study Protocol and Methods for Easing Pelvic Pain Interventions Clinical Research Program (EPPIC): a Randomized Clinical Trial of Brief, low-intensity, Transdiagnostic Cognitive Behavioral Therapy Vs Education/support for Urologic Chronic Pelvic...

Abstract

Background: Urologic chronic pelvic pain syndrome (UCPPS) encompasses several common, costly, diagnoses including interstitial cystitis/bladder pain syndrome and chronic prostatitis/chronic pelvic pain syndrome that are poorly understood and inadequately treated with conventional medical therapies. Behavioral strategies, recommended as a first-line treatment for managing symptoms, are largely inaccessible, time and labor intensive, and technically complex. The Easing Pelvic Pain Interventions Clinical Research Program (EPPIC) is a clinical trial examining the efficacy of low-intensity cognitive behavioral therapy (Minimal Contact CBT or MC-CBT) for UCPPS and its durability 3 and 6 months post treatment. Additional aims include characterizing the operative processes (e.g., cognitive distancing, context sensitivity, coping flexibility, repetitive negative thought) that drive MC-CBT-induced symptom relief and pre-treatment patient variables that moderate differential response.

Methods: UCPPS patients (240) ages 18-70 years, any gender, ethnicity, and race, will be randomized to 4-session MC-CBT or a credible, non-specific education comparator (EDU) that controls for the generic effects from simply going to treatment. Efficacy assessments will be administered at pre-treatment, 2 weeks, and 3 and 6 months post treatment-week acute phase. A novel statistical approach applied to micro-analytic mediator assessment schedule will permit the specification of the most effective CBT component(s) that drive symptom relief.

Discussion: Empirical validation of a low-intensity self-management therapy transdiagnostic in scope has the potential to improve the health of chronic pelvic pain patients refractory to medical therapies, reduce social and economic costs, conserve health care resources, as well as inform evidence-based practice guidelines. Identification of change mechanisms and moderators of treatment effects can provide proactive patient-treatment matching fundamental to goals of personalized medicine.

Trial Registration: Clinicaltrials.gov NCT05127616. Registered on 9/19/21.

Citing Articles

Therapeutic Approaches for Urologic Chronic Pelvic Pain Syndrome; Management: Research Advances, Experimental Targets, and Future Directions.

Ashraf S, Clarkson T, Malykhina A J Pharmacol Exp Ther. 2024; 390(2):222-232.

PMID: 38565309 PMC: 11264256. DOI: 10.1124/jpet.123.002081.


Cognitive Behavioral Therapy for Chronic Pelvic Pain: What Is It and Does It Work?.

Lackner J, Clemens J, Radziwon C, Danforth T, Ablove T, Krasner S J Urol. 2024; 211(4):539-550.

PMID: 38228093 PMC: 10939861. DOI: 10.1097/JU.0000000000003847.

References
1.
Dawes M, Summerskill W, Glasziou P, Cartabellotta A, Martin J, Hopayian K . Sicily statement on evidence-based practice. BMC Med Educ. 2005; 5(1):1. PMC: 544887. DOI: 10.1186/1472-6920-5-1. View

2.
Raine R, Haines A, Sensky T, Hutchings A, Larkin K, Black N . Systematic review of mental health interventions for patients with common somatic symptoms: can research evidence from secondary care be extrapolated to primary care?. BMJ. 2002; 325(7372):1082. PMC: 131187. DOI: 10.1136/bmj.325.7372.1082. View

3.
Mehling W, Acree M, Stewart A, Silas J, Jones A . The Multidimensional Assessment of Interoceptive Awareness, Version 2 (MAIA-2). PLoS One. 2018; 13(12):e0208034. PMC: 6279042. DOI: 10.1371/journal.pone.0208034. View

4.
Folkman S, Moskowitz J . Coping: pitfalls and promise. Annu Rev Psychol. 2004; 55:745-74. DOI: 10.1146/annurev.psych.55.090902.141456. View

5.
Lackner J, Keefer L, Jaccard J, Firth R, Brenner D, Bratten J . The Irritable Bowel Syndrome Outcome Study (IBSOS): rationale and design of a randomized, placebo-controlled trial with 12 month follow up of self- versus clinician-administered CBT for moderate to severe irritable bowel syndrome. Contemp Clin Trials. 2012; 33(6):1293-310. PMC: 3468694. DOI: 10.1016/j.cct.2012.07.013. View